{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Mesenchymal stromal cell",
      "SARS-CoV2"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32854985",
  "DateCompleted": {
    "Year": "2021",
    "Month": "03",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "08",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.blre.2020.100742",
      "S0268-960X(20)30092-8"
    ],
    "Journal": {
      "ISSN": "1532-1681",
      "JournalIssue": {
        "Volume": "46",
        "PubDate": {
          "Year": "2021",
          "Month": "Mar"
        }
      },
      "Title": "Blood reviews",
      "ISOAbbreviation": "Blood Rev"
    },
    "ArticleTitle": "Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?",
    "Pagination": {
      "StartPage": "100742",
      "MedlinePgn": "100742"
    },
    "Abstract": {
      "AbstractText": [
        "Mesenchymal stromal cells (MSC) have immune regulatory and tissue regenerative properties. MSCs are being studied as a therapy option for many inflammatory and immune disorders and are approved to treat acute graft-versus-host disease (GvHD). The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic and associated coronavirus infectious disease-19 (COVID-19) has claimed many lives. Innovative therapies are needed. Preliminary data using MSCs in the setting of acute respiratory distress syndrome (ARDS) in COVID-19 are emerging. We review mechanisms of action of MSCs in inflammatory and immune conditions and discuss a potential role in persons with COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Physiology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Department of Neuroscience, Baylor College of Medicine, Houston, TX, USA."
          }
        ],
        "LastName": "Hamdan",
        "ForeName": "Hamdan",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA; Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia."
          }
        ],
        "LastName": "Hashmi",
        "ForeName": "Shahrukh K",
        "Initials": "SK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Hematology and Oncology, Case Western Reserve University, Cleveland, OH, USA."
          }
        ],
        "LastName": "Lazarus",
        "ForeName": "Hillard",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Haematology Research Centre, Imperial College London, London, UK."
          }
        ],
        "LastName": "Gale",
        "ForeName": "Robert Peter",
        "Initials": "RP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pain Medicine, Mayo Clinic, Jacksonville, FL, USA; Center of Regenerative Medicine, Mayo Clinic, Jacksonville, FL, USA."
          }
        ],
        "LastName": "Qu",
        "ForeName": "Wenchun",
        "Initials": "W"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Oncology Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Electronic address: relfakih1@kfshrc.edu.sa."
          }
        ],
        "LastName": "El Fakih",
        "ForeName": "Riad",
        "Initials": "R"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Blood Rev",
    "NlmUniqueID": "8708558",
    "ISSNLinking": "0268-960X"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Mesenchymal Stem Cell Transplantation"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "Respiratory Distress Syndrome"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "None. cells."
}